IMO either one, with GIGL with the News out today it looks like it is a winner all the way. ENDV has had insider buys and a Institution taking a position. Your choice I would read the GIGL Board here and read the ENDV Board on I-H then decide.
Good Luck ! I own both.
(0)
(0)
Endonovo Therapeutics, Inc. (ENDV) Stock Research Links